Abemaciclib 50mg tablets
NHS hospitals in England used £62,861,076 of indicative cost of Abemaciclib 50mg tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 18.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Abemaciclib 50mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Abemaciclib 50mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £6,075,841 |
| Portsmouth Hospitals Nhs Trust | £2,706,625 |
| The Royal Marsden Nhs Foundation Trust | £2,085,755 |
| The Clatterbridge Cancer Centre Nhs Ft | £2,070,900 |
| Royal Surrey County Hosp Nhs Found Trust | £1,888,316 |
| Nottingham University Hospitals Trust | £1,695,513 |
| Southend Univ Hosp Nhs Foundation Trust | £1,488,907 |
| Sheffield Teaching Hospitals Nhs Trust | £1,446,238 |
| Oxford University Hospitals Nhs Ft | £1,436,281 |
| Leeds Teaching Hpls Nhs Trust | £1,312,750 |
The primary-care picture
Abemaciclib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Abemaciclib medicine page.